Volume 63, Issue 6, Pages (June 2013)

Slides:

Advertisements

Similar presentations

Differential drug responses of circulating tumor cells within patient blood Andrew D. Hughes, Jocelyn R. Marshall, Eric Keller, John D. Powderly, Bryan.

Advertisements

Pascal Rischmann European Urology Supplements

The PSA Era is not Over for Prostate Cancer

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 44, Issue 6, Pages (December 2003)

The Role of Tobacco Smoke in Bladder and Kidney Carcinogenesis: A Comparison of Exposures and Meta-analysis of Incidence and Mortality Risks Marcus G.

Volume 199, Issue 2, Pages (February 2018)

Volume 64, Issue 5, Pages (November 2013)

Volume 69, Issue 2, Pages (February 2016)

Association between Smoking, Passive Smoking, and Erectile Dysfunction: Results from the Boston Area Community Health (BACH) Survey Varant Kupelian,

Volume 69, Issue 1, Pages (January 2016)

Volume 71, Issue 4, Pages (April 2017)

Let the Games Begin (with EAU Approval)

Volume 68, Issue 1, Pages (July 2015)

Prostate Cancer Epidemic in Sight?

Volume 65, Issue 6, Pages (June 2014)

Volume 50, Issue 5, Pages (November 2006)

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Measuring the Urologic Iceberg: Design and Implementation of the Boston Area Community Health (BACH) Survey John B. McKinlay, Carol L. Link European.

Volume 54, Issue 4, Pages (October 2008)

Ute Ganswindt, Arnulf Stenzl, Michael Bamberg, Claus Belka

Volume 70, Issue 3, Pages (September 2016)

Prostate Cancer Detection: A View of the Future

P.M.J. Moonen, L.A.L.M. Kiemeney, J.A. Witjes European Urology

Volume 66, Issue 5, Pages (November 2014)

Low-risk Prostate Cancer: Identification, Management, and Outcomes

Volume 64, Issue 4, Pages (October 2013)

Volume 69, Issue 6, Pages (June 2016)

Volume 69, Issue 3, Pages (March 2016)

Volume 60, Issue 5, Pages (November 2011)

Shaheen Alanee, Kasmintan Schrader, Kenneth Offit European Urology

International Society of Urological Pathology Grading and Other Prognostic Factors for Renal Neoplasia Brett Delahunt, John R. Srigley, Lars Egevad,

Counselling the Prostate Cancer Patient

Prostate Cancer Epidemic in Sight?

James N. Armitage, Stuart O. Irving, Neil A. Burgess European Urology

The PSA Era is not Over for Prostate Cancer

Volume 64, Issue 4, Pages (October 2013)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 53, Issue 6, Pages (June 2008)

Mark A. Rubin, Gabriele Girelli, Francesca Demichelis European Urology

Volume 63, Issue 3, Pages (March 2013)

Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia

Volume 65, Issue 6, Pages (June 2014)

The Economic Costs of Overactive Bladder in Germany

Volume 62, Issue 6, Pages (December 2012)

Is Simple Enucleation a Minimal Partial Nephrectomy Responding to the EAU Guidelines’ Recommendations? Vincenzo Ficarra, Antonio Galfano, Stefano Cavalleri

Volume 50, Issue 5, Pages (November 2006)

CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System

Volume 55, Issue 3, Pages (March 2009)

Volume 50, Issue 2, Pages (August 2006)

Volume 52, Issue 6, Pages (December 2007)

Testicular Cancer Variations in Time and Space in Europe

Volume 54, Issue 6, Pages (December 2008)

Prospective, randomized, controlled trial of thoracic epidural or patient-controlled opiate analgesia on perioperative quality of life M. Ali, D.C. Winter,

The 20-Yr Outcome in Patients with Well- or Moderately Differentiated Clinically Localized Prostate Cancer Diagnosed in the Pre-PSA Era: The Prognostic.

Prognostic Impact of Comorbidity in Patients with Bladder Cancer

European Urology is “Your” Journal

Epidemiology of Renal Cell Carcinoma

The Start-Up of the Platinum Journal: A Fascinating Challenge

Prostate Cancer Screening Decreases the Absolute Risk of Being Diagnosed with Advanced Prostate Cancer—Results from a Prospective, Population-Based Randomized.

Economic Burden of Bladder Cancer Across the European Union

Prognostic Factors in Non–Muscle-Invasive Bladder Tumors

Volume 53, Issue 2, Pages (February 2008)

Early Single-Instillation Chemotherapy Has No Real Benefit and Should Be Abandoned in Non–Muscle-Invasive Bladder Cancer Sten Holmäng European Urology.

Clinical Management of Patients Receiving Tyrosine Kinase Inhibitors for Advanced Renal Cell Carcinoma Jan Roigas European Urology Supplements Volume.

Ian W. Mills, Anna Crossland, Anup Patel, Henrikas Ramonas

Physical Function in Patients with Cancer

Volume 54, Issue 1, Pages (July 2008)

European Urology Oncology

Volume 51, Issue 5, Pages (May 2007)

Presentation transcript:

Volume 63, Issue 6, Pages 1122-1127 (June 2013) Illness Uncertainty and Quality of Life of Patients with Small Renal Tumors Undergoing Watchful Waiting: A 2-year Prospective Study Patricia A. Parker, Frances Alba, Bryan Fellman, Diana L. Urbauer, Yisheng Li, Jose A. Karam, Nizar Tannir, Eric Jonasch, Christopher G. Wood, Surena F. Matin European Urology Volume 63, Issue 6, Pages 1122-1127 (June 2013) DOI: 10.1016/j.eururo.2013.01.034 Copyright © 2013 European Association of Urology Terms and Conditions

Fig. 1 Means and 95% confidence intervals for Cancer Rehabilitation Evaluation System–Short Form subscale scores over time (n=100 patients with small renal tumors). European Urology 2013 63, 1122-1127DOI: (10.1016/j.eururo.2013.01.034) Copyright © 2013 European Association of Urology Terms and Conditions

Fig. 2 Means and 95% confidence intervals for Physical Component Summary (PCS), Mental Component Summary (MCS), Impact of Event Scale (IES), and Mishel Uncertainty in Illness Scale (MUIS) scores over time (n=100 patients with small renal tumors). European Urology 2013 63, 1122-1127DOI: (10.1016/j.eururo.2013.01.034) Copyright © 2013 European Association of Urology Terms and Conditions